xAnts

Alphabet's AI-drug development could be a big tailwind, says Big Technology's Alex Kantrowitz

CNBC's Deirdre Bosa, Big Technology's Alex Kantrowitz and Wealth Enhancement's Ayako Yoshioka, join 'Closing Bell' to discuss Alphabet ahead of its earnings ...Read more